InterventionsReview

Obesity, incretin-based therapies, and cardiovascular disease in women

Fig. 1. Clinical considerations of obesity in women. — Fig. 1. Clinical considerations of obesity in women.Clinical considerations of obesity in women.Salih et al.

Netherlands Heart Journal

The paper

Miro Salih, Yannicke A. J. Sloots, Martin E. W. Hemels,

Laura M G Meems, Maarten J.G. Leening,

Chahinda Ghossein‐Doha

Erasmus MC

Netherlands Heart Journal · 16 Sep 2026

doi.org/10.1007/s12471-026-02084-0 PubMed 42747778

GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk
Diabetes, Obesity & Metabolism · 4 Oct 2026
Semaglutide improved heart artery function in pigs
Research Square · 8 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity
The New England Journal of Medicine · 4 Oct 2026
Orforglipron matches insulin glargine on cardiovascular safety
Lancet · 4 Oct 2026